Market Place
Sourcing Support
All News #Library
Rare Diseases
FDA approves Novo`s Sogroya as the first and only FDA Approval
28 Feb 2026 //
PR NEWSWIRE
Novo Nordisk Pens $2.1B Deal For Omeros` Stalled PNH Drug
15 Oct 2025 //
FIERCE BIOTECH
Novo to Advance Prothena`s Coramitug into Phase 3 for Amyloidosis
06 Aug 2025 //
BUSINESSWIRE
FDA Approves Alhemo for Hemophilia A/B Treatment in Children
31 Jul 2025 //
PR NEWSWIRE
Novo`s Ozempic Linked to Rare Cases of Serious Eye Disorder
09 Jun 2025 //
REUTERS
Novo Nordisk`s Ozempic faces EU review for potential eye disease connection
18 Dec 2024 //
REUTERS
Novo`s Ozempic faces scrutiny over potential link to rare eye disease
17 Dec 2024 //
REUTERS
Novo invests $1.2 bln in new rare disease drugs plant in Denmark
17 Dec 2024 //
REUTERS
Novo Nordisk Highlights Rare Blood Disorders at ASH 2024
03 Dec 2024 //
PR NEWSWIRE
US FDA approves Novo Nordisk`s therapy for rare genetic condition
03 Oct 2023 //
YAHOO FINANCE
Sanofi bets on India with portfolio of drugs for diabetes, rare diseases
13 Feb 2018 //
ECONOMIC TIMES
Sanofi, Novo back rare disease startup Inozyme
20 Nov 2017 //
FIERCE BIOTECH
Six new medicines backed for EU approval
28 Mar 2017 //
PHARMA TIMES
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.